Lipo-Xenopeptide Polyplexes for CRISPR/Cas9 based Gene editing at ultra-low dose-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lipo-Xenopeptide Polyplexes for CRISPR/Cas9 based Gene editing at ultra-low dose

Published:2024-06 Issue: Volume:370 Page:239-255
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Germer Janin,Lessl Anna-Lina,Pöhmerer Jana,Grau Melina,Weidinger Eric,Höhn Miriam,Yazdi Mina,Cappelluti Martino Alfredo,Lombardo Angelo,Lächelt Ulrich,Wagner Ernst

Funder

Horizon 2020

German Research Foundation

Publisher

Elsevier BV

Reference85 articles.

1. Cell & RNA Therapy Landscape Report, Q1;Gene,2024

2. mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability;Schoenmaker;Int. J. Pharm.,2021

3. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis;Adams;New Engl. J. Med.,2018

4. Nomenclature for synthetic gene delivery systems;Felgner;Hum. Gene Ther.,1997

5. Recent Advances in Non‐viral Gene Delivery

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies and mechanisms for endosomal escape of therapeutic nucleic acids;Current Opinion in Chemical Biology;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP